This little-known biotech stock has ‘blockbuster potential,’ says Citi
The bank predicts Cabaletta’s autoimmune disease treatment could help shares soar more than 65% from Friday’s close.
Meta employees are back in the office three days a week as part of new mandate
Meta’s return-to-office mandate requires employees to work from the company’s offices at least three days a week.
Illumina names new CEO months after Icahn proxy fight over Grail deal
The announcement comes after a proxy fight with activist investor Carl Icahn, which ended with Illumina’s former CEO Francis deSouza voluntarily stepping down.
Mortgage rate tipping point: Homeowners say roughly 5% is the magic number to move
At today’s financing rates, it could cost more to move, even into a less expensive home. That creates an incentive for homeowners to stay put.
Fed Governor Waller agrees the central bank can ‘proceed carefully’ on interest rates
Waller told CNBC on Tuesday that the recent round of strong economic data will buy the central bank some time.
Texas braces for the historic impeachment trial of Attorney General Ken Paxton
The conservative firebrand and key Trump ally has been accused of corruption by his own party. Here’s what you need to know about the trial.
Buy this home improvement retailer as tailwinds start adding up, Bernstein says
The firm upgraded shares to outperform from market perform.
Barclays says buy this software stock with AI tailwinds
The firm estimates Oracle shares have 24% upside potential, continuing its strong growth story over the past year.
RBC upgrades this credit card stock, says it can rally 25% despite uncertain consumer outlook
American Express remains better positioned among its consumer finance peers, according to RBC.
Goldman says now’s the time to buy this potato processing stock with 30% upside
Goldman estimates more than 30% upside for the food processing company’s shares.
